AUS
NZ
UK
CA
USA
IND
Healt
A Glimpse At Three Healthcare Stocks: OVN, ANP & BIT
July 26, 2019 08:55 PM AEST| By Team Kalkine MediaIn this piece of writing, we would discuss the three stocks from healthcare sector traded on the ASX. The Australian benchmark index S&P/ASX 200 closed at 6793.4, down by 24.60 points or 0.4% from the previous close, on 26 July 2019. Oventus Med...
2 Important Healthcare Stocks With IT Integration – VHT, PIQ
July 26, 2019 07:19 PM AEST| By Team Kalkine MediaAustralian healthcare industry challenges include an ageing population, increased rate of chronic diseases, emergence and integration of new technologies, etc. Some important Australian companies, which are working on integrating ?SaaS? model in the...
SUDA’s MD and CEO, Mr Stephen Carter Back on Board
July 25, 2019 06:35 PM AEST| By Team Kalkine MediaAn oro-mucosal drug delivery company headquartered in Perth, SUDA Pharmaceuticals Ltd (ASX: SUD) uses its OroMist? technology for the development of low-risk oral sprays. The company reformulates the existing pharmaceuticals into an oral spray to bet...
Journey of Prescient Therapeutics in 2019
July 25, 2019 12:38 PM AEST| By Team Kalkine MediaPrescient Therapeutics Limited (ASX: PTX) is a clinical-stage oncology company that works on mutation causing cancer. The existing product portfolio of the company includes two drug candidates, PTX 100 and PTX 200, under the development phase. Both...
Noxopharm Eyes The Development Of A Well-Tolerated ‘STING agonist’ Drug
July 24, 2019 04:54 PM AEST| By Team Kalkine MediaNoxopharm Limited (ASX: NOX) has released July 2019 edition of its Newsletter called 'Versatility'. The clinical-stage drug development company, Noxopharm reports on the progress of its lead anti-cancer drug candidate Veyonda? achieved over the past...
Three Stocks from the Health Care Sector: ATX, SOM & M7T
July 24, 2019 12:52 PM AEST| By Team Kalkine MediaIn this article, we would discuss three healthcare stocks from ASX. On 23 July 2019, these companies have released significant updates pertaining to their respective business. The Australian benchmark index was trading at 6,780.6, up by 55.4 points (...
Recent Updates On 4 Healthcare Stocks- BNO, MDR, KZA, OPT
July 22, 2019 10:34 PM AEST| By Team Kalkine MediaCompanies and institutions that provide medical assistance and services, manufactures of medical equipment, engage in clinical trials and development of drugs, are part of the healthcare sector. The Australian government makes significant contributio...
An Overview Of IMU’s B-Cell Vaccines’ Clinical Trials
July 22, 2019 07:22 PM AEST| By Team Kalkine MediaAn Australian-based biotechnology company, Imugene Limited (ASX: IMU) focuses on the development of cancer immunotherapies targeted at activating the immune system of cancer patients. The company?s exceptional platform technology helps in stimulating...
SUDA Receives Patent For The Only Effective Medicine For Platelet Reduction, Anagrelide; Stock Soars 33%
July 22, 2019 05:46 PM AEST| By Team Kalkine MediaWith the rise in cases of the deadly disease cancer creating havoc across the globe, it is the need of the hour for the pharma participants to gear up and provide cure and treatment solutions to this global concern. With the huge market opportunity,...
3 Healthcare Stocks Shining on ASX – MVP, RHT, CYP
July 22, 2019 02:23 PM AEST| By Team Kalkine MediaHealthcare being a large industry in Australia is a significant contributor to the country?s economy. The below-mentioned ASX listed healthcare stocks have been performing well over the past few months, plus have made strong operational progress as r...
3 Healthcare Stocks Good To Look At - API, SIG, HLS
July 20, 2019 04:02 PM AEST| By Team Kalkine MediaAccording to the World Health Organisation, about $6.5 trillion is spent on the healthcare every year globally. With the global demand for healthcare products and services growing significantly, investment in the healthcare sector seems to be a good...
Australian Biopharma Player, Immuron Reports 29% Record Revenue Growth for FY19
July 19, 2019 10:10 PM AEST| By Team Kalkine MediaAustralian biopharmaceutical company,Immuron Limited (ASX: IMC), headquartered in Carlton, is engaged in developing and commercialising orally delivered targeted polyclonal antibodies for the treatment of inflammatory mediated and infectious diseases...
A Look At Four ASX-Listed Biotech Stocks With Significant YTD Returns – PNV, TLX, BOT, CUV
July 17, 2019 08:26 PM AEST| By Team Kalkine MediaThe biotechnology sector is one of those sectors that presents an incredible opportunity for huge returns to investors. This is because the business of curing diseases can be lucrative, and any company with a small market capitalisation can be worth...
Recent Updates On 4 Healthcare Stocks- 1AD, IMC, NEU & SCU
July 17, 2019 05:46 PM AEST| By Team Kalkine MediaHealthcare Healthcare sector comprises of the companies that offer medical services, producing medical equipment or medicines. These companies also give medical insurance to the patients. In Australia, the funding of healthcare is taken care of by...
Prescient Therapeutics’ Cancer Trials Backed By A Robust Product Portfolio
July 17, 2019 04:15 PM AEST| By Team Kalkine MediaClinical stage oncology company Prescient Therapeutics Limited (ASX: PTX) is in the process of developing a breakthrough to traditional therapies by its novel drug candidates that have shown great promise in the treatment of a range of cancers that h...
Prescient Therapeutics starts Phase 1b clinical trial of its unique inhibitor PTX-100
July 16, 2019 03:56 PM AEST| By Team Kalkine MediaOn 11 July 2019, Prescient Therapeutics Limited (ASX: PTX) announced the commencement of a Phase 1b trial of its second targeted anti-cancer drug PTX-100 in patients with multiple cancers. The trial would reportedly be led by one of the world?s leadi...
Imugene Expands Immunotherapy Platform, Announces Licensing of Oncolytic Virus CF33 from City of Hope Cancer Centre
July 16, 2019 01:13 PM AEST| By Team Kalkine MediaA biotech company headquartered in Australia, Imugene Limited (ASX: IMU) develops new and novel immunotherapies that seek to harness the cancer patients? immune system against tumors. The company?s unique platform technologies seeks to potentially ac...
4 Healthcare Stocks With Recent Updates - RNO, TLX, BOT, PAA
July 15, 2019 10:51 PM AEST| By Team Kalkine MediaThe below-mentioned healthcare stocks have provided significant returns in the last six months and have come up with major updates today (i.e. 15th July 2019).? Let?s take a look at these updates. Rhinomed Limited (ASX: RNO) A Melbourne-based tech...
Noxopharm’s clinical programs aiming to unveil a potential blockbuster drug in the cancer treatment spectrum
July 15, 2019 02:20 PM AEST| By Team Kalkine MediaClinical stage drug development company, Noxopharm Limited (ASX: NOX) aims to bring hope to cancer patients who have reached the end of their treatment journey and have no standard treatment options remaining, except palliative therapy for pain-relie...
Three Australian Healthcare Players- API, SIG, HLS
July 15, 2019 01:32 PM AEST| By Team Kalkine Media?Health is wealth? stands true when it comes to the overall growth and development of the economy. As the emphasis on health is strong and significant in every society, with evolving time, the health care sector has risen to become a booming business...
Advertise your brand on Kalkine Media